tiprankstipranks
Trending News
More News >
EuroEyes International Eye Clinic Limited (HK:1846)
:1846
Hong Kong Market
Advertisement

EuroEyes International Eye Clinic Limited (1846) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

1846 Financial Forecast

1846 Earnings Forecast

The previous quarter’s earnings for 1846 were HK$0.12.
The previous quarter’s earnings for 1846 were HK$0.12.

1846 Sales Forecast

The previous quarter’s earnings for 1846 were HK$377.13M.
The previous quarter’s earnings for 1846 were HK$377.13M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on HK:1846
TR | OpenAI - 4o
TR | OpenAI - 4o
HK$3.5
Hold
15.13%
Upside
Reiterated
10/18/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on HK:1846
TR | OpenAI - 4o
TR | OpenAI - 4o
HK$3.5
Hold
15.13%
Upside
Reiterated
10/18/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1846 Analyst Recommendation Trends

Rating
Apr 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
1
6
5
5
0
Hold
1
3
5
5
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
9
10
10
7
In the current month, 1846 has received 0 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. 1846 average Analyst price target in the past 3 months is 3.50.
Each month's total comprises the sum of three months' worth of ratings.

1846 Stock Forecast FAQ

What is HK:1846’s average 12-month price target, according to analysts?
Based on analyst ratings, EuroEyes International Eye Clinic Limited’s 12-month average price target is 3.50.
    What is HK:1846’s upside potential, based on the analysts’ average price target?
    EuroEyes International Eye Clinic Limited has 15.13% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EuroEyes International Eye Clinic Limited a Buy, Sell or Hold?
          EuroEyes International Eye Clinic Limited has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is EuroEyes International Eye Clinic Limited’s share price target?
            The average share price target for EuroEyes International Eye Clinic Limited is 3.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$3.50 ,and the lowest forecast is HK$3.50. The average share price target represents 15.13% Increase from the current price of HK$3.04.
              What do analysts say about EuroEyes International Eye Clinic Limited?
              EuroEyes International Eye Clinic Limited’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of EuroEyes International Eye Clinic Limited?
                To buy shares of HK:1846, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis